Clinical Trial: Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder

Brief Summary: This study will examine the utility of the neuropeptide oxytocin (OT) as a potential new medication for the treatment of Alcohol use disorder (AUD). Non-treatment seeking men and women with AUD will be enrolled in a double blind placebo controlled phase I clinical trial. Participants will complete an 7-day inpatient protocol. During the first 3 days of the inpatient protocol, participants will complete alcohol abstinence in which withdrawal symptoms are measured,and urine will be collected to determine withdrawal symptom severity and urine levels of the stress hormone cortisol. Participants will then complete 3 laboratory procedures which measure 1) stress response, 2) motivation to drink alcohol and 3) subjective and physiological effects of alcohol. Finally, because participants are individuals with AUD, we will administer a brief intervention to address their risky alcohol drinking and problems before discharge.